DÉCANOATE D'HALOPÉRIDOL INJECTABLE Solution
국가: 캐나다
언어: 프랑스어
출처: Health Canada
제품 특성 요약
(SPC)
27-05-2020
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
유효 성분:
Halopéridol (Décanoate d'halopéridol)
제공처:
STRIDES PHARMA CANADA INC
ATC 코드:
N05AD01
INN (International Name):
HALOPERIDOL
복용량:
100MG
약제 형태:
Solution
구성:
Halopéridol (Décanoate d'halopéridol) 100MG
관리 경로:
Intramusculaire
패키지 단위:
1ML/5ML
처방전 유형:
Prescription
치료 영역:
BUTYROPHENONES
제품 요약:
Numéro de groupe d'ingrédients actifs (GIA) :0101774008; AHFS:
승인 상태:
APPROUVÉ
승인 날짜:
2020-05-27
제품 특성 요약
3
0212 5 3,('(352'8,7
3U
'pFDQRDH G
DORSpULGROLQMHFDEOH
'pFDQRDH G
DORSpULGROLQMHFDEOH
PJH
PJG
DORSpULGROP/
6ROX LRQVpULOH SRXU LQMHFLRQLQUDPXVFXODLUH
17,36
27,
8(
1
R
GHFRQ UOHGH ODSUpVHQD LRQ
-3
DUHQQHV
XHEHF
RXO
/LRQHORXOH
6ULGHV3DUPDDQDGD ,QF
'DHGHUpYLVLRQ
PDL
3
0212 5 3,('(352'8,7
3U
'pFDQRDWH G KDORSpULGROLQMHFWDEOH
'pFDQRDWH GKDORSpULGRO,QMHFWDEOH
PJHW PJ GKDORSpULGROP/
/66,),
7,217e53(87,8(
QWLSVFKRWLTXH
02'( '
7,21 (73
50
2/2 ,(/,1,
8(
/HGpFDQRDWH G KDORSpULGROXQ GpULYpHVWHU GHOKDORSpULGROREWHQX SDUOD
FRQGHQVDWLRQ
GHO KDORSpULGRO DYHFGHODFLGHGpFDQRwTXH
SRVVqGHOHVSURSULpWpVDQWLSVFKRWLTXHVGH
OKDORSpULGRO /RUVTX LO HVWDGPLQLVWUp VRXV IRUPH
GLPSODQWLQWUDPXVFXODLUH,0GDQVGH
OKXLOH GHVpVDPHOHVHVWpUDVHVSUpVHQWHV GDQVOHVDQJ HWOHVWLVVXVK GURO
VHQWOH
GpFDQRDWHGKDORSpULGROHWDVVXUHQWXQHOLEpUDWLRQOHQWH GHO KDORSpULGRO
QHXUROHSWLTXH
DFWLI
GH OLPSODQWMXVTXj GDQVOD FLUFXODWLRQVVWpPLTXH /H GpODLGDFWLRQHVW GH
TXHOTXHVMRXUVDSUqV OLQMHFWLRQ HWO HIIHW WKpUDSHXWLTXH
VHPDLQWLHQWSHQGDQWj
VHPDLQHV ELHQTX RQ SXLVVHIUpTXHPPHQW REWHQLUXQFRQWUOHDGpTXDWDX PR HQGH
LQMHFWLRQ WRXWHVOHV
VHPDLQHV ,OHVWQpFHVVDLUHG H[HUFHU XQH VXUYHLOODQFHpWURLWHWRXW
DXORQJGXWUDLWHPHQW FRPSWHWHQX GHV
YDULDWLRQVHQWUHOHVUpSRQVHVLQGLYLGXHOOHV
/HGpFDQRDWH G KDORSpULGROSRVVqGHGHVSURSULpWpVDQWLpPpWLTXHV ,O
SUpVHQWHXQH
WHQGDQFH PDUTXpHjSURYRTXHUGHVHIIHWVH[WUDS UDPLGDX[HWLOFRPSRUWHGHV
SURSULpWpV DOSKD DGUpQROWLTXHVUHODWLYHPHQWIDLEOHV ,OSHXW
pJDOHPHQWSUpVHQWHU GHV
HIIHWVKSRWKHUPLTXHVHW DQRUH[LDQWVHWSRWHQWLDOLVHUO DFWLRQ
GHVEDUELWXULTXHVGHV
DQHVWKpVLTXHVJpQpUDX[HW DXWUHV GpSUHVVHXUVGX61&
&RPPHGDQVOH FDVGDXWUHVQHXUROHSWLTXHV OH PpFDQLVPHGDFWLRQ GX GpFDQRDWH
G KDORSpULGRO QD SDVHQFRUHpWpHQWLqUHPHQWpOXFLGpPDLVLODpWpDWWULEXp
jOLQKLELWLRQ
GXPpFDQLVPHGH WUDQVSRUWGHVPRQRDPLQHVFpUpEUDOHVSDUOKDORSpULGRO
3
SDUWLFXOLqUHPHQWHQLQKLEDQWODWUDQVPLVVLRQ GLPSXOVLRQVGDQVOHVQHXURQHV
GRSDPLQHUJLTXHV
3 DUPDFRFLQpLTXH
/DSKDUPDFRFLQpWLTXHDpWppWXGLpH FKH]GHVSDWLHQWVDWWHLQWVGXQ
WURXEOHSVFKRWLTXH
FKURQLTXH
HWUHFHYDQWGHVLQMHFWLRQVPHQVXHOOHVSHQGDQWXQHSpULRGHDOODQWMXVTXj
DQV /DGRVH LQLWLDOHDpWpIRQ
전체 문서 읽기
